These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9288144

  • 1. Design of a potent novel endotoxin antagonist.
    Uknis ME, Wasiluk KR, Acton RD, Klaerner HG, Dahlberg PS, Ilyina EE, Haseman JR, Gray BH, Mayo KH, Dunn DL.
    Surgery; 1997 Aug; 122(2):380-5. PubMed ID: 9288144
    [Abstract] [Full Text] [Related]

  • 2. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS, Acton RD, Battafarano RJ, Uknis ME, Ratz CA, Johnston JW, Haseman JR, Gray BH, Dunn DL.
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [Abstract] [Full Text] [Related]

  • 3. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ, Dahlberg PS, Ratz CA, Johnston JW, Gray BH, Haseman JR, Mayo KH, Dunn DL.
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [Abstract] [Full Text] [Related]

  • 4. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE, Weiss J, Doerfler ME, Elsbach P.
    J Exp Med; 1991 Sep 01; 174(3):649-55. PubMed ID: 1875165
    [Abstract] [Full Text] [Related]

  • 5. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein.
    Wasiluk KR, Leslie DB, Vietzen PS, Mayo KH, Dunn DL.
    Surgery; 2004 Aug 01; 136(2):253-60. PubMed ID: 15300188
    [Abstract] [Full Text] [Related]

  • 6. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J, Elsbach P, Shu C, Castillo J, Grinna L, Horwitz A, Theofan G.
    J Clin Invest; 1992 Sep 01; 90(3):1122-30. PubMed ID: 1522221
    [Abstract] [Full Text] [Related]

  • 7. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z, Hong Z, Guo W, Xiaoyun G, Gengfa L, Yongning L, Guangxia X.
    Int Immunopharmacol; 2004 Apr 01; 4(4):527-37. PubMed ID: 15099530
    [Abstract] [Full Text] [Related]

  • 8. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW.
    J Immunol; 1992 Jan 15; 148(2):532-7. PubMed ID: 1729370
    [Abstract] [Full Text] [Related]

  • 9. Comparison of endotoxin antagonism of linear and cyclized peptides derived from limulus anti-lipopolysaccharide factor.
    Leslie DB, Vietzen PS, Lazaron V, Wasiluk KR, Dunn DL.
    Surg Infect (Larchmt); 2006 Feb 15; 7(1):45-52. PubMed ID: 16509785
    [Abstract] [Full Text] [Related]

  • 10. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

  • 11. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
    Weiss CA, Wasiluk KR, Kellogg TA, Dunn DL.
    Surgery; 2000 Aug 15; 128(2):339-44. PubMed ID: 10923014
    [Abstract] [Full Text] [Related]

  • 12. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
    Zhou H.
    Zhonghua Shao Shang Za Zhi; 2001 Apr 15; 17(2):102-4. PubMed ID: 11876922
    [Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide binding and antibacterial activities of a synthetic peptide representing amino acids 90-101 of bactericidal/permeability-increasing protein.
    Yeh TM, Chao SC, Chang HC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Aug 15; 27(3):120-32. PubMed ID: 9747342
    [Abstract] [Full Text] [Related]

  • 14. Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities.
    Mayo KH, Haseman J, Ilyina E, Gray B.
    Biochim Biophys Acta; 1998 Sep 16; 1425(1):81-92. PubMed ID: 9813253
    [Abstract] [Full Text] [Related]

  • 15. A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.
    Mészáros K, Parent JB, Gazzano-Santoro H, Little R, Horwitz A, Parsons T, Theofan G, Grinna L, Weickmann J, Elsbach P.
    J Leukoc Biol; 1993 Dec 16; 54(6):558-63. PubMed ID: 8245707
    [Abstract] [Full Text] [Related]

  • 16. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
    Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW.
    J Immunol; 1990 Jan 15; 144(2):662-6. PubMed ID: 2295804
    [Abstract] [Full Text] [Related]

  • 17. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock.
    Dankesreiter S, Hoess A, Schneider-Mergener J, Wagner H, Miethke T.
    J Immunol; 2000 May 01; 164(9):4804-11. PubMed ID: 10779788
    [Abstract] [Full Text] [Related]

  • 18. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
    Gazzano-Santoro H, Mészáros K, Birr C, Carroll SF, Theofan G, Horwitz AH, Lim E, Aberle S, Kasler H, Parent JB.
    Infect Immun; 1994 Apr 01; 62(4):1185-91. PubMed ID: 8132325
    [Abstract] [Full Text] [Related]

  • 19. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins.
    Marra MN, Thornton MB, Snable JL, Leong S, Lane J, Wilde CG, Scott RW.
    Blood Purif; 1993 Apr 01; 11(2):134-40. PubMed ID: 7506040
    [Abstract] [Full Text] [Related]

  • 20. Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins.
    Chen X, Dings RP, Nesmelova I, Debbert S, Haseman JR, Maxwell J, Hoye TR, Mayo KH.
    J Med Chem; 2006 Dec 28; 49(26):7754-65. PubMed ID: 17181157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.